Sainz, T.; Diaz, L.; Rojo, D.; Clemente, M.I.; Barbas, C.; Gosalbes, M.J.; Jimenez-Hernandez, N.; Escosa, L.; Guillen, S.; Ramos, J.T.;
et al. Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial. Nutrients 2022, 14, 992.
https://doi.org/10.3390/nu14050992
AMA Style
Sainz T, Diaz L, Rojo D, Clemente MI, Barbas C, Gosalbes MJ, Jimenez-Hernandez N, Escosa L, Guillen S, Ramos JT,
et al. Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial. Nutrients. 2022; 14(5):992.
https://doi.org/10.3390/nu14050992
Chicago/Turabian Style
Sainz, Talía, Laura Diaz, David Rojo, María Isabel Clemente, Coral Barbas, María José Gosalbes, Nuria Jimenez-Hernandez, Luis Escosa, Sara Guillen, José Tomás Ramos,
and et al. 2022. "Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial" Nutrients 14, no. 5: 992.
https://doi.org/10.3390/nu14050992
APA Style
Sainz, T., Diaz, L., Rojo, D., Clemente, M. I., Barbas, C., Gosalbes, M. J., Jimenez-Hernandez, N., Escosa, L., Guillen, S., Ramos, J. T., Muñoz-Fernández, M. Á., Navarro, M. L., Mellado, M. J., & Serrano-Villar, S.
(2022). Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial. Nutrients, 14(5), 992.
https://doi.org/10.3390/nu14050992
